Global Doxycycline Hyclate Capsules Market to Grow at a CAGR of 4.7% According to a newly published market research report by 24LifeSciences, global doxycycline hyclate oral capsules market was valued at USD 481 million in 2024 and is projected to reach USD 662 million by 2031, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2025–2031. Doxycycline hyclate, a semi-synthetic tetracycline-class antibiotic, is widely prescribed for its broad-spectrum efficacy against a diverse range of bacterial infections, including respiratory infections, sexually transmitted diseases like chlamydia, acne vulgaris, urinary tract infections, Lyme disease, and certain parasitic infections. Its bacteriostatic action, which inhibits protein synthesis in susceptible bacteria, along with its favorable pharmacokinetic profile, continues to make it a cornerstone therapy in both clinical and outpatient settings globally. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3962/doxycycline-hyclate-oral-capsules-market